Triamcinolone acetonide and Tarceva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triamcinolone acetonide (triamcinolone acetonide) and Tarceva (erlotinib hydrochloride). Common drug interactions include diverticulitis among females and dry skin among males.

The phase IV clinical study analyzes what interactions people have when they take Triamcinolone acetonide and Tarceva. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Triamcinolone acetonide?

Triamcinolone acetonide has active ingredients of triamcinolone acetonide. It is often used in eczema. eHealthMe is studying from 19,593 Triamcinolone acetonide users. Check the latest studies of Triamcinolone acetonide.

What is Tarceva?

Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.



On Feb, 02, 2026

29 people who take Triamcinolone acetonide and Tarceva together, and have interactions are studied.

Triamcinolone acetonide and Tarceva drug interactions.

What are the common drug interactions of Triamcinolone Acetonide and Tarceva, by gender? *:

female:

  1. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  2. Cystitis (inflammation of the wall of the bladder)
  3. Endometrial cancer
  4. Dizziness
  5. Dry skin
  6. Dysphonia (speech disorder attributable to a disorder of phonation)
  7. Dyspnoea exertional (breathlessness or shortness of breath)
  8. Pleural effusion (water on the lungs)
  9. Rash pruritic (redness with itching)
  10. Drug ineffective

male:

  1. Dry skin
  2. Nausea (feeling of having an urge to vomit)
  3. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  4. Pruritus (severe itching of the skin)
  5. Rash erythematous (redness of the skin)
  6. Rash pruritic (redness with itching)
  7. Swelling face
  8. Therapeutic response decreased (less preventive response)
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Vision blurred

What are the common drug interactions of Triamcinolone Acetonide and Tarceva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Constipation
  2. Fatigue (feeling of tiredness)
  3. Headache (pain in head)
  4. Muscular weakness (muscle weakness)
  5. Nausea (feeling of having an urge to vomit)
  6. Oral fungal infection
  7. Confusional state
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Disease progression
  10. Disorientation (disability in which the senses of time, direction, and recognition of people and places)

40-49:

n/a

50-59:

n/a

60+:

  1. Dry skin
  2. Diarrhoea
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Eye irritation
  5. Heart rate irregular
  6. Hypoacusis (loss of hearing)
  7. Nail discolouration (change in nail colour)
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Pleural effusion (water on the lungs)
  10. Rash erythematous (redness of the skin)

What are the existing conditions these people have? *

  1. Lung Neoplasm Malignant (cancer tumour of lung): 22 people, 75.86%
  2. Pain: 4 people, 13.79%
  3. Nausea (feeling of having an urge to vomit): 4 people, 13.79%
  4. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 13.79%
  5. Rashes (redness): 2 people, 6.90%
  6. Oral Fungal Infection: 2 people, 6.90%
  7. Brain Neoplasm Malignant (brain cancer tumour): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone acetonide and Tarceva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Triamcinolone acetonide and Tarceva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Triamcinolone acetonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tarceva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triamcinolone acetonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tarceva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide and erlotinib hydrochloride (the active ingredients of Triamcinolone acetonide and Tarceva, respectively), and Triamcinolone acetonide and Tarceva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: